Abstract
Seventy-six human immunodeficiency virus (HIV)-infected patients with Staphylococcus aureus nasal carriage were randomized to treatment groups receiving intranasal mupirocin or placebo twice daily for 5 days. Nasal cultures for S. aureus were obtained at 1, 2, 6, and 10 weeks after therapy. At 1 week, 88% of mupirocin-treated patients had negative nasal cultures compared with 8% in placebo patients (P
Cite
CITATION STYLE
Martin, J. N., Perdreau-Remington, F., Kartalija, M., Pasi, O. G., Webb, M., Gerberding, J. L., … Lee, B. L. (1999). A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Journal of Infectious Diseases, 180(3), 896–899. https://doi.org/10.1086/314949
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
